ClinicalTrials.govpublic full text
ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
coronary artery disease, lexiscan, regadenoson, adenoscan®, adenosine, spect myocardial perfusion imaging, reversible perfusion defect, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842259
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.